Skip to main content
. 2021 Mar 19;22(8):1048–1059. doi: 10.1007/s11121-021-01221-y

Table 3.

Outcome measures at baseline and 3-month follow-up across CG and IG

Control group Intervention group
Baseline (n = 30) 3 months (n = 27) p value Baseline (n = 27) 3 months (n = 23) p value Group-time interaction p value
Frailty status 1.33 ± 0.55 1.07 ± 0.73 0.034* 1.30 ± 0.54 0.96 ± 0.77 0.010* 0.637
HGS (kg) 17.40 ± 3.95 18.64 ± 4.81 0.020* 18.10 ± 3.65 18.70 ± 4.52 0.117 0.642
KES (kg) 16.66 ± 5.89 16.56 ± 4.22 0.928 15.87 ± 5.83 17.00 ± 4.82 0.197 0.313
TUG (s) 9.22 ± 3.27 9.50 ± 4.13 0.706 8.92 ± 2.49 8.32 ± 2.27 0.071 0.113
SPPB (pt) 10.90 ± 1.65 10.81 ± 2.00 0.937 10.85 ± 1.46 11.52 ± 0.73 0.008* 0.043*
Balance (pt) 3.73 ± 0.58 3.59 ± 0.80 0.169 3.67 ± 0.68 3.74 ± 0.54 0.622 0.195
Gait speed (pt) 3.73 ± 0.58 3.70 ± 0.67 0.938 3.78 ± 0.58 3.91 ± 0.29 0.327 0.439
Chair stand (pt) 3.43 ± 1.04 3.44 ± 1.09 0.628 3.41 ± 0.69 3.87 ± 0.34 0.002* 0.045*

Model adjusted for age, gender, and physical activity levels

Data presented in mean ± SD

HGS handgrip strength, KES knee extensor strength, TUG timed up and go, SPPB short physical performance battery

*p < 0.05